Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Pfizer

More Headlines »« Less Headlines

Pfizer, Inc. () () is an American multinational pharmaceutical corporation founded in 1849. The company is headquartered in Midtown Manhattan, New York City, with its research headquarters in Groton, Connecticut, United States.

Read More at Wikipedia ›

Related Topics

  1. Wyeth
  2. Bristol-Myers Squibb
  3. Ranbaxy Laboratories
  4. Eli Lilly
  5. Food And Drug Administration
  6. IMS Health
Get updates on Pfizer
Shareholder 'Smart Bombs' Shaking Up Proxy Meetings

Shareholder meetings tend to be dull, pro forma affairs held at sterile conference centers and highlighted by an earnest chief executive who checks off a list of accomplishments for the past year and a list of goals for the year ahead.

Key items of business such as executive compensation and the re-election of the chairman and board of directors usually occur with hardly a whisper of opposition. Lone dissenters are taken in stride, a part of the annual proceedings, acknowledged politely and briefly by the smiling CEO.The curtain may be falling on these rote performances, however, as bolder and wiser shareholder activists use increasingly sophisticated techniques to target their opposition causes with pinpoint precision."I think we're seeing more proxy season smart bombs. That's the difference," said Ralph Ward, publisher of the Boardroom Insider and an expert on corporate governance.Shareholder activism has always played a role in steering the course of public companies, but the causes ...

Read More ›

  1. Mylan Launches Generic Lipitor In France, U.K.

    Mylan Inc. said Friday it's launching sales of its generic version of the popular cardiovascular medicine Lipitor in France, Belgium, the U.K., the Netherlands and I...

  2. Lupin Fourth-Quarter Net Profit Falls 31%, Misses View

    Indian generic-drug maker Lupin Ltd. (500257.BY) Thursday missed market expectations with a 31% drop in net profit for the fourth quarter as a higher tax outgo offse...

  3. WSJ BLOG/Health: A.M. Vitals: Pfizer Parts With Lipitor

    Here's what's making health news this morning:Goodbye, Lipitor. Pfizer Bids a Farewell (WSJ): After an $87 million marketing push since November, Pfizer is giving up...

  4. FDA Panel Recommends Approval Of Pfizer's Tofacitinib

    A federal advisory panel backed the approval of a proposed Pfizer Inc. (PFE) drug for rheumatoid arthritis, but recommended limits on the types of patients who shoul...

  5. Teva 1Q Profit Up 13% On Branded, Generic Drug Sales

    Teva Pharmaceutical Industries Ltd. (TEVA) said Wednesday its first-quarter profit rose 13%, as sales growth for branded and generic drugs in the U.S. and emerging m...

  6. Abbott To Pay $1.6 Billion To Settle Depakote Marketing Probes

    Abbott Laboratories (ABT) agreed to pay $1.6 billion and plead guilty to violating a federal drug law to resolve allegations that the company improperly promoted ant...

  7. Pfizer's Pristiq Shows Positive Results In Long-Term Study

    Pfizer Inc. (PFE) said its Pristiq extended-release antidepressant showed positive results in a long-term study of adults when compared with a placebo.The pharmaceut...

  8. FDA:Questions Safety, Effectiveness Of Proposed Pfizer Arthritis Drug

    The Food and Drug Administration questioned the safety and effectiveness of a proposed Pfizer Inc. (PFE) drug for rheumatoid arthritis.The drug, tofacitinib, is desi...

  9. Pfizer's Lyrica Nerve-Pain Drug Fails To Meet Endpoint In Diabetes Study

    Pfizer Inc. (PFE) reported disappointing results from a Phase 3 trial that tested its blockbuster Lyrica drug as a treatment for patients suffering with diabetes-rel...

  10. Pfizer Axes Late-Stage Lyrica Study

    Pfizer (NYSE:PFE) reported disappointing results from a late-stage trial of pain drug Lyrica for diabetes-related nerve damage on Friday and said it was putting the ...

  11. Novartis To Acquire Dermatology Generics Co Fougera For $1.53 Billion

    Novartis AG (NVS, NOVN.VX) signed a definitive agreement to acquire New York-based specialty dermatology generics company Fougera Pharmaceuticals for $1.53 billion i...

  12. FDA Approves Protalix, Pfizer Drug To Treat Gaucher Disease

    The U.S. Food and Drug Administration on Tuesday approved a new treatment developed by Protalix BioTherapeutics Inc. (PLX, PLX.TV) for adults with a type of Gaucher ...

  1. FDA Panel: Data Could Support Approval Of Pfizer Drug Tafamidis

    A Food and Drug Administration advisory panel said a clinical study submitted by Pfizer Inc. (PFE) for a drug to treat a rare genetic disorder that affects the nervo...

  2. FDA Panel Votes Against Expanded Approval Of Bayer, J&J's Xarelto

    A Food and Drug Administration advisory panel narrowly voted against expanded use of Johnson & Johnson's (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting drug Xare...

  3. FDA Reviewer Recommends Against Approval Of Pfizer Drug

    A Food and Drug Administration medical reviewer recommended the agency not approve a drug developed by a Pfizer Inc. (PFE) subsidiary to treat a rare genetic disorde...

  4. FDA Reviewer Backs Expanded Approval Of Bayer, J&J's Xarelto

    A Food and Drug Administration medical reviewer recommended the agency expand the approval of Johnson & Johnson's (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting ...

  5. Pfizer Recalls Advil Bottles From Distributors

    Pfizer Inc. has recalled about 650,000 bottles of its popular Advil Liqui-Gel pain reliever from its retail-distribution centers over concerns that they carry an unu...

  6. WSJ BLOG/Health: A.M. Vitals: U.S. Lowers Bar on Lead Poisoning

    Here's what's making health news this morning:Federal Officials Tighten Lead Limits for Kids (WSJ): The Centers for Disease Control and Prevention redefined poisonin...

  7. Dr Reddy's Jan-March Net Grows 2.7%; Misses View On One-Time Charge

    Dr. Reddy's Laboratories Ltd. (500124.BY) Friday disappointed investors with a slim 2.7% rise in its fourth-quarter net profit, but this was due mainly to a one-time...

‹ Prev12345…Next ›
Freebase CC-BY
Source: Pfizer on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL